Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports on the safety and tolerability of administering MEDI-528 in multiple doses to adults with mild persistent asthma, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MEDI-528

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-11